Tested Applications
| Positive WB detected in | U2OS cells, LNCaP cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
67913-1-Ig targets OSBPL5 in WB, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag11554 Product name: Recombinant human OSBPL5 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-353 aa of BC032646 Sequence: MKEEAFLRRRFSLCPPSSTPQKVDPRKLTRNLLLSGDNELYPLSPGKDMEPNGPSLPRDEGPPTPSSATKVPPAEYRLCNGSDKECVSPTARVTKKETLKAQKENYRQEKKRATRQLLSALTDPSVVIMADSLKGPKGESVGSITQPLPSSYLIFRAASESDGRCWLDALELALRCSSLLRLGTCKPGRDGEPGTSPDASPSSLCGLPASATVHPDQDLFPLNGSSLENDAFSDKSERENPEESDTETQDHSRKTESGSDQSETPGAPVRRGTTYVEQVQEELGELGEASQVETVSEENKSLMWTLLKQLRPGMDLSRVVLPTFVLEPRSFLNKLSDYYYHADLLSRAAVEED Predict reactive species |
| Full Name | oxysterol binding protein-like 5 |
| Calculated Molecular Weight | 811 aa, 91 kDa |
| Observed Molecular Weight | 110-120 kDa |
| GenBank Accession Number | BC032646 |
| Gene Symbol | OSBPL5 |
| Gene ID (NCBI) | 114879 |
| RRID | AB_3085041 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein G purification |
| UNIPROT ID | Q9H0X9 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for OSBPL5 antibody 67913-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The OSBPL5 Monoclonal antibody (2A1C1), catalog number 67913-1-Ig, has 1 total citation. It appears in Cell Reports in Medicine (2026), in a study investigating how lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in triple-negative breast cancer (TNBC). The research fields associated with this citation include ferroptosis, mitochondrial biology, and breast cancer.
| Species | Application | Title |
|---|---|---|
Cell Rep Med Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC. |
